Bank of New York Mellon Corp - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 20 filers reported holding TENAX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$20,000
-60.0%
35,139
-1.2%
0.00%
Q4 2019$50,000
+16.3%
35,571
+0.0%
0.00%
Q3 2019$43,000
-12.2%
35,5700.0%0.00%
Q2 2019$49,000
-34.7%
35,570
-3.6%
0.00%
Q1 2019$75,000
+63.0%
36,911
-3.1%
0.00%
Q4 2018$46,00038,0770.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
FAS Wealth Partners, Inc. 58,576$70,0000.01%
Virtu Financial LLC 17,503$21,0000.00%
A.R.T. Advisors, LLC 10,225$12,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 12,200$15,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,018$6,0000.00%
UBS Group AG 9,161$11,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of TENAX THERAPEUTICS INC shareholders